{
    "nct_id": "NCT04908709",
    "official_title": "Spectroscopic MRI Guided Proton Therapy for Pediatric High-Grade Glioma (RAD4500)",
    "inclusion_criteria": "* Pathologically diagnosed high-grade glioma (World Health Organization [WHO] grade 3-4). Patients with a radiographically diagnosed high-grade glioma may enroll prior to pathologic confirmation, but would be removed from study if pathology did not confirm the diagnosis of high-grade glioma.\n* Primary tumor located within the supratentorial brain.\n* Recommended to receive definitive radiation therapy.\n* Able to receive MRI scans.\n* Both males and females, and members of all races and ethnic groups are eligible for this trial.\nHealthy volunteers allowed\nMust have maximum age of 21 Years",
    "exclusion_criteria": "* Patients with pacemakers, non-titanium aneurysm clips, neurostimulators, cochlear implants, non-titanium metal in ocular structures, or other incompatible implants which makes MRI safety an issue are excluded.\n* Patients that have any significant medical illnesses that in the investigator's opinion cannot be adequately tolerate MRI scan are excluded.\n* Pathology demonstrated low-grade glioma or other benign or non-invasive brain tumor.",
    "miscellaneous_criteria": ""
}